Molécules compléments

Sous-catégories

• 

  Dosage ELISA proteines...

  <table cellpadding="10" style="width:100%;border-collapse:collapse;" border="1"><thead><tr><th>Désignation</th><th>Référence</th><th>Conditionnement</th><th>Régulation</th></tr></thead><tbody><tr><td>Factor H Anti-Complement</td> <td>ODZ-166</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3a Mouse</td> <td>TE1038</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Porcine Cytokine - High Sensitivity (4-plex)</td> <td>119149PC</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Rat Cytokine - Screen (9-plex)</td> <td>110449RT</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine Panel 2 (6-plex)</td> <td>115349MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine Panel 2 (4-plex)</td> <td>115549MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine Panel 1 (6-plex)</td> <td>115249MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine Panel 1 (4-plex)</td> <td>115449MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine - Stripwells (16-plex)</td> <td>110349MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine - Screen (16-plex)</td> <td>110949MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Mouse Cytokine - Inflammation (14-plex)</td> <td>110449MS</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Obesity (7-plex)</td> <td>119049HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human MMP (6-plex)</td> <td>340949HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Micronutrient (7-Plex)</td> <td>565149HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human IL-1 Family (10-plex)</td> <td>118649HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Female Hormone (8-plex)</td> <td>332149HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine Panel 2 (6-plex)</td> <td>115333HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine Panel 1 (6-Plex)</td> <td>115233HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine (4-Plex)</td> <td>115433HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine - Stripwells (16-plex)</td> <td>110333HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine - Inflammation (9-plex)</td> <td>110433HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine - High Sensitivity Screen (15-plex)</td> <td>112433HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine - High Sensitivity (9-plex)</td> <td>114433HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Chemokine (9-plex)</td> <td>120233HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Chemokine (4-plex)</td> <td>125433HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Angiogenesis (9-plex)</td> <td>150233HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Q-Plex Human Cytokine - Screen (16-plex)</td> <td>110933HU</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 8-Plex (10 Kit Minimum order)</td> <td>A908</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 7-Plex (10 Kit Minimum order)</td> <td>A907</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 6-Plex (10 Kit Minimum order)</td> <td>A906</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 5-Plex (10 Kit Minimum order)</td> <td>A905</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 4-Plex (10 Kit Minimum order)</td> <td>A904</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Custom 3-Plex (10 Kit Minimum order)</td> <td>A903</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>MicroVue Std 8-Plex (C4A,Ba, Bb, C3a, C5a, Sc5b-9, FH, FI)</td> <td>A900</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>iC3b</td> <td>A006</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Facteur H Anti-Complément</td> <td>ODZ-166</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>CIC-C3d (Raji-Cell-Remplacement)</td> <td>A002</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>CIC-C1q</td> <td>A001</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>CH50 Eq</td> <td>A018</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C5a</td> <td>A025</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C4d</td> <td>A008</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td><span style="text-decoration:underline;color:#2445a2;"><a href="https://eurobio-scientific.eu/fr/sciences-de-la-vie/2216-c4a.html"><span style="color:#2445a2;text-decoration:underline;">C4a</span></a></span></td> <td>A036</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3a souris</td> <td>TE1038</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td><span style="text-decoration:underline;color:#2445a2;"><a href="https://eurobio-scientific.eu/fr/sciences-de-la-vie/2213-c1-inhibiteur-plus.html"><span style="color:#2445a2;text-decoration:underline;">C1-Inhibiteur Plus</span></a></span></td> <td>A037</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Fraction Ba</td> <td>A034</td> <td>96 tests</td> <td>RUO</td> </tr></tbody></table>
• 

  Anticorps du complément

  <table cellpadding="10" style="width:100%;border-collapse:collapse;" border="1"><thead><tr><th>Désignation</th><th>Référence</th><th>Conditionnement</th><th>Régulation</th></tr></thead><tbody><tr><td>Anti-Facteur Bb biotinylé</td> <td>A712</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>AntiSC5b-9 (néoantigène) biotinylé</td> <td>A711</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-iC3b (néoantigène) biotinylé</td> <td>A710</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C9 biotinylé</td> <td>A709</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C8 biotinylé</td> <td>A708</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C7 biotinylé</td> <td>A707</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C6 biotinylé</td> <td>A706</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C5 biotinylé</td> <td>A705</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C4d biotinylé</td> <td>A704</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C4c biotinylé</td> <td>A703</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C3d biotinylé</td> <td>A702</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C3c biotinylé</td> <td>A701</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Anti-C1q biotinylé</td> <td>A700</td> <td>250 µL</td> <td>RUO</td> </tr><tr><td>Facteur I</td> <td>A313</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>Facteur H</td> <td>A312</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>Facteur B</td> <td>A311</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C9</td> <td>A310</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C8</td> <td>A309</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C7</td> <td>A308</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C6</td> <td>A307</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C5</td> <td>A306</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C4</td> <td>A305</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C3</td> <td>A304</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C2 (fraction Ig)</td> <td>A303</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C1s</td> <td>A302</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C1q</td> <td>A301</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>C1-Inhibiteur</td> <td>A300</td> <td>2 mL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur H _3</td> <td>A255</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur H _2</td> <td>A254</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C4d (néoantigène)</td> <td>A253</td> <td>0,5 mL</td> <td>RUO</td> </tr><tr><td>Anti-human Bb (néoantigène)</td> <td>A252</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C4d (néoantigène)</td> <td>A251</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C3d (néoantigène)</td> <td>A250</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Clustérine (SP40, 40, Apo J)</td> <td>A241</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human SC5b-9 (néoantigène TCC)</td> <td>A239</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human S-Proteine (vitronectine)</td> <td>A237</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur P _2</td> <td>A235</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur P _1</td> <td>A233</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur I _2</td> <td>A231</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur I _1</td> <td>A247</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur H</td> <td>A229</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur B (Bb)</td> <td>A227</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human Facteur B (Ba)</td> <td>A225</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C9</td> <td>A223</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C8</td> <td>A249</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C7</td> <td>A221</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C6</td> <td>A219</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C5</td> <td>A217</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C4 (binding protein)</td> <td>A215</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C4d</td> <td>A213</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C4c</td> <td>A211</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human iC3b (néoantigène)</td> <td>A209</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C3d</td> <td>A207</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C3c</td> <td>A205</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C3a</td> <td>A203</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Anti-human C1q</td> <td>A201</td> <td>100 µL</td> <td>RUO</td> </tr><tr><td>Solution stabilisante pour échantillons</td> <td>A9576</td> <td>25 mL</td> <td>RUO</td> </tr><tr><td>Réactant de C1 inhibiteur</td> <td>A9527</td> <td>1 flacon</td> <td>RUO</td> </tr><tr><td>Facteur de venin de cobra</td> <td>A600</td> <td>&gt;= 350U/mL</td> <td>RUO</td> </tr><tr><td>Complément de sérum normal de cobaye</td> <td>A119</td> <td>5 mL</td> <td>RUO</td> </tr><tr><td>Sérum normal humain activé par facteur de venin de cobra</td> <td>A116</td> <td>0,1 mL</td> <td>RUO</td> </tr><tr><td>Panel d'échantillons du complément</td> <td>A115</td> <td>10 x 25 µL</td> <td>RUO</td> </tr><tr><td>Activateur de complément</td> <td>A114</td> <td>0,2 mL</td> <td>RUO</td> </tr><tr><td>Complément humain normal</td> <td>A113</td> <td>5 mL</td> <td>RUO</td> </tr><tr><td>Complément humain normal</td> <td>A112</td> <td>2,5 mL</td> <td>RUO</td> </tr><tr><td>Standard de complément humain (étalon)</td> <td>A100</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>Facteur P-dpl</td> <td>A512</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>Facteur B-dpl</td> <td>A506</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C9-dpl</td> <td>A505</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C8-dpl</td> <td>A504</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C7-dpl</td> <td>A503</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C6-dpl</td> <td>A502</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C5-dpl</td> <td>A501</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C4-Déficient</td> <td>A507</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C3/C4 Depleted</td> <td>A521</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C3-dpl</td> <td>A508</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C2-dpl</td> <td>A500</td> <td>1 mL</td> <td>RUO</td> </tr><tr><td>C1q-dpl</td> <td>A509</td> <td>1 mL</td> <td>RUO</td> </tr></tbody></table>
• 

  Sérum déplétès complément

  <table cellpadding="10" style="width:100%;border-collapse:collapse;" border="1"><tbody><tr><th>Désignation</th><th>Référence</th><th>Conditionnement</th><th>Régulation</th></tr><tr><td>C4 Depleted Human</td> <td>A522</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor H Depleted</td> <td>A523</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor I Depleted</td> <td>A524</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor D Depleted</td> <td>A525</td> <td>96 tests</td> <td>RUO</td> </tr></tbody></table>
• 

  Protéines du complément

  <table cellpadding="10" style="width:100%;border-collapse:collapse;" border="1"><thead><tr><th>Désignation</th><th>Référence</th><th>Conditionnement</th><th>Régulation</th></tr></thead><tbody><tr><td>C4b</td> <td>A428</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 2</td> <td>A427</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C1 Esterase Inhibitor</td> <td>A426</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C1r Enzyme</td> <td>A424</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>iC3b</td> <td>A423</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor Ba</td> <td>A422</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C5a</td> <td>A420</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C4a</td> <td>A419</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3d</td> <td>A418</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3c</td> <td>A417</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor Bb</td> <td>A416</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>SC5b-9</td> <td>A415</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor P</td> <td>A412</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor I</td> <td>A411</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor H</td> <td>A410</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor D (is provided at 0.1 mg/ml)</td> <td>A409</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>Factor B</td> <td>A408</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 9</td> <td>A407</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 8</td> <td>A406</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 7</td> <td>A405</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 6</td> <td>A404</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 5</td> <td>A403</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 4</td> <td>A402</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3b</td> <td>A413</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C3a</td> <td>A414</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C 3</td> <td>A401</td> <td>96 tests</td> <td>RUO</td> </tr><tr><td>C1q</td> <td>A400</td> <td>96 tests</td> <td>RUO</td> </tr></tbody></table>
• 

  Divers complément